Lewes, Delaware, July 17, 2024 (GLOBE NEWSWIRE) -- The Global Gene Therapy Market Size is projected to grow at a CAGR of 26.88% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 7.53 Billion in 2024 and is expected to reach USD 50.6 Billion by the end of the forecast period.
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=40223
Browse in-depth TOC on “Global Gene Therapy Market Size”
202 - Pages
126 – Tables
37 – Figures
Scope Of The Report
| REPORT ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2021-2031 |
| BASE YEAR | 2024 |
| FORECAST PERIOD | 2024-2031 |
| HISTORICAL PERIOD | 2021-2023 |
| UNIT | Value (USD Billion) |
| KEY COMPANIES PROFILED | Pfizer, Novartis AG, Biogen, Gilead Sciences, Inc., MolMed S.p.A., Spark Therapeutics, Inc., Orchard Therapeutics plc., SIBIONO, Bluebird bio, Inc., Shanghai Sunway Biotech Co. Ltd. |
| SEGMENTS COVERED | By Product, By Indication, By Delivery Method, And By Geography |
| CUSTOMIZATION SCOPE | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Gene Therapy Market Overview
Technological Advancements in Genetic Engineering: The gene therapy market is being propelled forward by rapid breakthroughs in genetic engineering technologies. These advancements improve the accuracy and effectiveness of gene therapies, which in turn attract investments and stimulate market expansion. Maintaining a lead in the use of technology guarantees a competitive advantage and creates opportunities for generating additional income.
Increasing Prevalence of Genetic Disorders: The increasing prevalence of genetic abnormalities worldwide is a major factor contributing to the growth of the gene therapy market. The increasing number of patients in search of efficient treatments has led to a boom in the demand for gene therapies. The increasing number of patients presents significant prospects for enterprises to enhance their market share and impact.
Favorable Regulatory Environment: The time-to-market for gene therapies is being reduced as a result of the acceleration of the approval process by supportive regulatory frameworks. Regulatory agencies are increasingly acknowledging the potential of gene therapy, offering incentives and streamlined development pathways. This advantageous environment fosters investment and innovation, which in turn propels market expansion.
To Purchase a Comprehensive Report Analysis: https://www.verifiedmarketresearch.com/download-sample?rid=40223
High Treatment Costs: The exorbitant expenses linked to gene therapy treatments continue to be a substantial obstacle. These expenditures have the potential to restrict patient availability and burden healthcare budgets. Businesses must prioritize cost-reduction measures and implement value-based pricing models in order to overcome this obstacle and improve their market penetration.
Ethical and Safety Concerns: The gene therapy market is constrained by ethical issues and potential safety risks. Public acceptance and regulatory clearances can be impeded by concerns regarding the long-term effects of genetic changes. To achieve market expansion, it is necessary to address these concerns by implementing transparent communication and strict safety measures.
Limited Healthcare Infrastructure in Developing Regions: The lack of sufficient healthcare infrastructure in underdeveloped nations hinders the implementation of gene treatments. The market expansion can be hindered by the limited availability of advanced medical facilities and experienced professionals. Establishing strategic alliances and making investments in healthcare development are crucial in order to access these new markets and stimulate future expansion.
Geographic Dominance:
North America has a strong hold on the gene therapy market because of its well-developed healthcare infrastructure, substantial investments in research and development, and favorable regulatory rules. This dominance expedites market expansion as the region evolves into a center for innovation, enticing multinational corporations and promoting progress. The market expansion is also facilitated by Europe's robust biopharmaceutical industry and favorable laws. On the other hand, the Asia-Pacific region exhibits significant potential for quick expansion as a result of escalating investments in healthcare and a growing emphasis on genetic research.
Gene Therapy Market Key Players Shaping the Future
Major players, including Pfizer, Novartis AG, Biogen, Gilead Sciences, Inc., MolMed S.p.A., Spark Therapeutics, Inc., Orchard Therapeutics plc., SIBIONO, Bluebird bio, Inc., Shanghai Sunway Biotech Co. Ltd. and more, play a pivotal role in shaping the future of the Gene Therapy Market. Financial statements, product benchmarking, and SWOT analysis provide valuable insights into the industry's key players.
Gene Therapy Market Segment Analysis
Based on the research, Verified Market Research® has segmented the global Gene Therapy Market into Product, Indication, Delivery Method, And Geography.
To get market data, market insights, and a comprehensive analysis of the Global Gene Therapy Market, please Contact Verified Market Research®.
- Gene Therapy Market, by Product
- Viral Vectors
- Non-viral Vectors
- Gene Therapy Market, by Indication
- Neurological Diseases
- Cancer
- Hepatological Diseases
- Duchenne Muscular Dystrophy
- Other Indications
- Gene Therapy Market, by Delivery Method
- Ex vivo
- In vivo
- Gene Therapy Market, by Geography
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- U.K
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- ROW
- Middle East & Africa
- Latin America
- North America
Browse Related Reports:
Global Viral Vector Plasmid DNA Manufacturing Market Size By Workflow (Upstream Processing, Downstream Processing), By Application (Cell Therapy, Gene Therapy), By End User (Biotech Companies, Pharmaceutical Companies), By Geography, And Forecast
Global Cell Therapy And Tissue Engineering Market Size By Material (Biologically Derived, Synthetic), By Type (Cell Therapy, Tissue Engineering), By Application (Genetic Diseases, Tissue Malignancy), By Geography, And Forecast
Global Direct-To-Consumer (DTC) Genetic Testing Market Size By Test Type (Carrier Testing, Predictive Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips), By End-User (Laboratories, Hospitals, Home Care), By Geography, And Forecast
Global Gene Synthesis Market Size By Method (Solid-phase synthesis, Chip-based synthesis, PCR- based Enzyme synthesis), Service (Antibody DNA synthesis, Viral DNA synthesis), Application (Gene & Cell therapy development, Vaccine development, Diseases diagnosis), End-User (Biotechnology & pharmaceutical companies, Academic & government research institutes, Contract research organizations), By Geography, And Forecast
10 Best Cell And Gene Therapy Companies unlocking potential of DNA
Visualize Gene Therapy Market using Verified Market Intelligence -:
Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
About Us
Verified Market Research® stands at the forefront as a global leader in Research and Consulting, offering unparalleled analytical research solutions that empower organizations with the insights needed for critical business decisions. Celebrating 10+ years of service, VMR has been instrumental in providing founders and companies with precise, up-to-date research data.
With a team of 500+ Analysts and subject matter experts, VMR leverages internationally recognized research methodologies for data collection and analyses, covering over 15,000 high impact and niche markets. This robust team ensures data integrity and offers insights that are both informative and actionable, tailored to the strategic needs of businesses across various industries.
VMR's domain expertise is recognized across 14 key industries, including Semiconductor & Electronics, Healthcare & Pharmaceuticals, Energy, Technology, Automobiles, Defense, Mining, Manufacturing, Retail, and Agriculture & Food. In-depth market analysis cover over 52 countries, with advanced data collection methods and sophisticated research techniques being utilized. This approach allows for actionable insights to be furnished by seasoned analysts, equipping clients with the essential knowledge necessary for critical revenue decisions across these varied and vital industries.
Verified Market Research® is also a member of ESOMAR, an organization renowned for setting the benchmark in ethical and professional standards in market research. This affiliation highlights VMR's dedication to conducting research with integrity and reliability, ensuring that the insights offered are not only valuable but also ethically sourced and respected worldwide.
